GENEVA - The World Health Organisation (WHO) on Nov 19 approved an mpox vaccine from Japanese pharma company KM Biologics for emergency use, the second one to get the agency’s seal of approval.

The first mpox vaccine approved by the WHO is MVA-BN, made by Bavarian Nordic A/S. It was approved for emergency use and can be used "off-label" in infants, children and adolescents as well as in ...

The only other vaccine being used against the mpox outbreak is Bavarian ... In Europe, it is known as Imvanex, where it is also approved in adults and adolescents, the latter indication coming ...

Adults started getting vaccinations against mpox in Democratic Republic of Congo's capital this week. But there were no shots ...

A second mpox vaccine ... has the highest number of cases of the virus. WHO approved Danish vaccine maker Bavarian Nordic's jab in September, adding that it may be used in infants, children, and ...